iGenomeDx
iGenomeDx is a San Antonio-based molecular diagnostics laboratory dedicated to providing fast, accurate, and actionable results for healthcare providers and patients. Founded by scientists with expertise in genetic research, the company leverages cutting-edge technologies such as PCR and LCMS to deliver a comprehensive menu of diagnostic services, including infectious disease detection, pharmacogenomics, genetic risk assessment, and drug monitoring. iGenomeDx's mission is to enhance clinical decision-making, improve patient care, and reduce healthcare costs through reliable and innovative laboratory solutions. The company is recognized for its commitment to quality, diversity, and community engagement, holding multiple certifications and industry awards. iGenomeDx aims to be the most trusted genetic testing and drug monitoring laboratory in San Antonio, with a vision centered on precision diagnostics, scientific integrity, and excellent customer service.
Industries
Nr. of Employees
small (1-50)
iGenomeDx
2040 BABCOCK ROAD STE 201, SAN ANTONIO, TX 78229
Products
DNA-Based Infectious Disease Testing
A diagnostic service using DNA fragment primers to detect bacterial, viral, and fungal pathogens from patient samples for accurate infectious disease identification.
Pharmacogenomics Testing
Genetic testing service analyzing patient DNA to predict individual responses to medications, guiding personalized drug therapy and dosage.
COVID-19 Testing
PCR-based nucleic acid amplification test using nasopharyngeal swabs to detect SARS-CoV-2 infection.
Molecular Diagnostic Test Panels for Infectious Diseases
Comprehensive panels testing for multiple pathogens causing respiratory, urinary tract, sexually transmitted, gastrointestinal, wound, and nail infections.
Medication Management Testing via Saliva and Urine
Testing service using saliva and urine samples to support medication management and monitoring.
DNA-Based Infectious Disease Testing
A diagnostic service using DNA fragment primers to detect bacterial, viral, and fungal pathogens from patient samples for accurate infectious disease identification.
Pharmacogenomics Testing
Genetic testing service analyzing patient DNA to predict individual responses to medications, guiding personalized drug therapy and dosage.
COVID-19 Testing
PCR-based nucleic acid amplification test using nasopharyngeal swabs to detect SARS-CoV-2 infection.
Molecular Diagnostic Test Panels for Infectious Diseases
Comprehensive panels testing for multiple pathogens causing respiratory, urinary tract, sexually transmitted, gastrointestinal, wound, and nail infections.
Medication Management Testing via Saliva and Urine
Testing service using saliva and urine samples to support medication management and monitoring.
Expertise Areas
- Molecular diagnostics
- Infectious disease testing (molecular)
- Pharmacogenomics and medication guidance
- Clinical toxicology and drug monitoring
Key Technologies
- Polymerase chain reaction (PCR/RT-PCR)
- Nucleic acid amplification
- Next-generation sequencing (NGS)
- Liquid chromatography–mass spectrometry (LC‑MS)
Key People
Co-Founder
Co-Founder
Co-Founder
Co-Founder
News & Updates
iGenomeDx was awarded the 2022 Minority-Owned Small Business of the Year by the U.S. Small Business Administration.
iGenomeDx is certified as a Women-owned, Minority-owned, Asian-owned, and Small Business by the South Central Texas Regional Certification Agency (SCTRCA).
iGenomeDx is a Gold Sponsor of the Bexar County Medical Society and has been serving San Antonio with molecular diagnostics services, including COVID-19 tests.
Article on the utilization of urine drug tests to manage patients, authored by James Shurko, PhD and Niti Vanee, PhD.
Discussion on enterovirus-associated acute respiratory illness and the importance of molecular testing.
Dr. Shurko, Laboratory Scientist at iGenomeDx, presented a CME presentation to the members of Bexar County Psychiatric Society.
iGenomeDx was awarded the 2022 Minority-Owned Small Business of the Year by the U.S. Small Business Administration.
iGenomeDx is certified as a Women-owned, Minority-owned, Asian-owned, and Small Business by the South Central Texas Regional Certification Agency (SCTRCA).
iGenomeDx is a Gold Sponsor of the Bexar County Medical Society and has been serving San Antonio with molecular diagnostics services, including COVID-19 tests.
Article on the utilization of urine drug tests to manage patients, authored by James Shurko, PhD and Niti Vanee, PhD.
Discussion on enterovirus-associated acute respiratory illness and the importance of molecular testing.
Dr. Shurko, Laboratory Scientist at iGenomeDx, presented a CME presentation to the members of Bexar County Psychiatric Society.